These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 20615694)
21. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis. Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377 [TBL] [Abstract][Full Text] [Related]
22. Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives. Usuki T; Sato M; Hara S; Yoshimoto Y; Kondo R; Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M Bioorg Med Chem Lett; 2014 Feb; 24(3):794-8. PubMed ID: 24433861 [TBL] [Abstract][Full Text] [Related]
23. Structural Insights into the Development of Cycloguanil Derivatives as Landi G; Linciano P; Borsari C; Bertolacini CP; Moraes CB; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Costi MP; Pozzi C; Mangani S ACS Infect Dis; 2019 Jul; 5(7):1105-1114. PubMed ID: 31012301 [TBL] [Abstract][Full Text] [Related]
24. Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei. Kelly JM; Taylor MC; Horn D; Loza E; Kalvinsh I; Björkling F Bioorg Med Chem Lett; 2012 Mar; 22(5):1886-90. PubMed ID: 22326398 [TBL] [Abstract][Full Text] [Related]
25. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds. Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582 [TBL] [Abstract][Full Text] [Related]
26. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug. Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820 [TBL] [Abstract][Full Text] [Related]
27. Benzimidazole inhibitors of the major cysteine protease of Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332 [No Abstract] [Full Text] [Related]
28. Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity. Spencer J; Rathnam RP; Harvey AL; Clements CJ; Clark RL; Barrett MP; Wong PE; Male L; Coles SJ; Mackay SP Bioorg Med Chem; 2011 Mar; 19(5):1802-15. PubMed ID: 21306904 [TBL] [Abstract][Full Text] [Related]
29. Activity of Aromathecins against African Trypanosomes. Nenortas NP; Cinelli MA; Morrell AE; Cushman M; Shapiro TA Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104277 [TBL] [Abstract][Full Text] [Related]
30. Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African Trypanosomiasis. Klug DM; Mavrogiannaki EM; Forbes KC; Silva L; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Garcia-Hernández R; Bosch-Navarrete C; Cordón-Obras C; Gómez-Liñán C; Saura A; Momper JD; Martinez-Martinez MS; Manzano P; Syed A; El-Sakkary N; Caffrey CR; Gamarro F; Ruiz-Perez LM; Gonzalez Pacanowska D; Ferrins L; Navarro M; Pollastri MP J Med Chem; 2021 Jul; 64(13):9404-9430. PubMed ID: 34156862 [TBL] [Abstract][Full Text] [Related]
31. Identification and development of the 1,4-benzodiazepin-2-one and quinazoline-2,4-dione scaffolds as submicromolar inhibitors of HAT. Clark RL; Clements CJ; Barrett MP; Mackay SP; Rathnam RP; Owusu-Dapaah G; Spencer J; Huggan JK Bioorg Med Chem; 2012 Oct; 20(20):6019-33. PubMed ID: 22985960 [TBL] [Abstract][Full Text] [Related]
32. Ornithine uptake and the modulation of drug sensitivity in Macedo JP; Currier RB; Wirdnam C; Horn D; Alsford S; Rentsch D FASEB J; 2017 Oct; 31(10):4649-4660. PubMed ID: 28679527 [No Abstract] [Full Text] [Related]
33. Structure-activity relationships for new organometallic complexes active against bloodstream forms of Trypanosoma brucei brucei. Loiseau PM; Gutierrez-Rios MT; De Frutos MI; Craciunescu DG Parasitol Res; 2001 Jul; 87(7):566-9. PubMed ID: 11484855 [No Abstract] [Full Text] [Related]
34. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent. Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877 [TBL] [Abstract][Full Text] [Related]
35. Trypanocidal activity of dicationic compounds related to pentamidine. Donkor IO; Assefa H; Rattendi D; Lane S; Vargas M; Goldberg B; Bacchi C Eur J Med Chem; 2001 Jun; 36(6):531-8. PubMed ID: 11525843 [TBL] [Abstract][Full Text] [Related]
36. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness. Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325 [TBL] [Abstract][Full Text] [Related]